Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Day

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Agents and Actions. Supplements|January 1, 1993
Variability in response to NSAIDs: what progress?R O Day
Medicine and Science in Sports and Exercise|January 1, 1981
Effects of exercise performance on drugs used in musculoskeletal disordersR O Day
Australian Family Physician|June 1, 1987
Non steroidal anti-inflammatory drugsR O Day
The Medical Journal of Australia|February 15, 1988
Mode of action of non-steroidal anti-inflammatory drugsR O Day
Clinical and Experimental Rheumatology|November 7, 2001
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspectiveR O Day
Agents and Actions. Supplements|January 1, 1985
Variability in response to NSAIDR O Day
Journal of Clinical Pharmacology|May 1, 1979
Deafness due to aspirinR O Day
Agents and Actions. Supplements|January 1, 1988
The contribution of enantiomers to variability in response to anti-inflammatory drugsK M Williams, R O Day
The Medical Journal of Australia|February 24, 2001
Pharmacotherapeutics: what a difference five decades makes!R O Day, M L Mashford
Journal of Pharmaceutical Sciences|December 1, 1983
High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteersJ E Ray, R O Day
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Agents and Actions. Supplements|January 1, 1993
Variability in response to NSAIDs: what progress?R O Day
Medicine and Science in Sports and Exercise|January 1, 1981
Effects of exercise performance on drugs used in musculoskeletal disordersR O Day
Australian Family Physician|June 1, 1987
Non steroidal anti-inflammatory drugsR O Day
The Medical Journal of Australia|February 15, 1988
Mode of action of non-steroidal anti-inflammatory drugsR O Day
Clinical and Experimental Rheumatology|November 7, 2001
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspectiveR O Day
Agents and Actions. Supplements|January 1, 1985
Variability in response to NSAIDR O Day
Journal of Clinical Pharmacology|May 1, 1979
Deafness due to aspirinR O Day
Agents and Actions. Supplements|January 1, 1988
The contribution of enantiomers to variability in response to anti-inflammatory drugsK M Williams, R O Day
The Medical Journal of Australia|February 24, 2001
Pharmacotherapeutics: what a difference five decades makes!R O Day, M L Mashford
Journal of Pharmaceutical Sciences|December 1, 1983
High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteersJ E Ray, R O Day
Pageof 19